Cargando…

Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus

Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Azka, Ali, Akhtar, Kumar, Dilpat, Kumar, Ravi, Elahi, Kanwal, Suman, FNU, Anjum, Zauraiz, Tharwani, Payal, Jahangir, Maha, Rizwan, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290906/
https://www.ncbi.nlm.nih.gov/pubmed/34295575
http://dx.doi.org/10.7759/cureus.15716
_version_ 1783724547004956672
author Ali, Azka
Ali, Akhtar
Kumar, Dilpat
Kumar, Ravi
Elahi, Kanwal
Suman, FNU
Anjum, Zauraiz
Tharwani, Payal
Jahangir, Maha
Rizwan, Amber
author_facet Ali, Azka
Ali, Akhtar
Kumar, Dilpat
Kumar, Ravi
Elahi, Kanwal
Suman, FNU
Anjum, Zauraiz
Tharwani, Payal
Jahangir, Maha
Rizwan, Amber
author_sort Ali, Azka
collection PubMed
description Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening as compared to other diseases, like diabetes mellitus (DM). Therefore, this study aims to compare the risk of CVD among patients with RA and DM. Methods This prospective study was carried out in Pakistan’s two tertiary care hospitals. A total of 750 participants were enrolled in three groups with a 1:1:1 ratio; patients with RA, type 2 DM, and the control group. Patients were observed for 12 months or until the development of a major adverse cardiovascular event (MACE), whichever occurred first. Results Both fatal (12.66% vs. 13.48%; p-value: 0.79) and non-fatal (3.93% vs. 4.35%; p-value: 0.82) MI was comparable between both RA and DM group. However, compared to the control group, non-fatal MI (12.66% vs. 5.58%; p-value: 0.01) was significantly higher in the RA group. Conclusion Our study shows that RA and DM have an equal risk of cardiovascular (CV) events. It is important that RA should be considered as a prominent risk factor for CV events. The management of these patients should be multidisciplinary, including cardiologists.
format Online
Article
Text
id pubmed-8290906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-82909062021-07-21 Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus Ali, Azka Ali, Akhtar Kumar, Dilpat Kumar, Ravi Elahi, Kanwal Suman, FNU Anjum, Zauraiz Tharwani, Payal Jahangir, Maha Rizwan, Amber Cureus Cardiology Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening as compared to other diseases, like diabetes mellitus (DM). Therefore, this study aims to compare the risk of CVD among patients with RA and DM. Methods This prospective study was carried out in Pakistan’s two tertiary care hospitals. A total of 750 participants were enrolled in three groups with a 1:1:1 ratio; patients with RA, type 2 DM, and the control group. Patients were observed for 12 months or until the development of a major adverse cardiovascular event (MACE), whichever occurred first. Results Both fatal (12.66% vs. 13.48%; p-value: 0.79) and non-fatal (3.93% vs. 4.35%; p-value: 0.82) MI was comparable between both RA and DM group. However, compared to the control group, non-fatal MI (12.66% vs. 5.58%; p-value: 0.01) was significantly higher in the RA group. Conclusion Our study shows that RA and DM have an equal risk of cardiovascular (CV) events. It is important that RA should be considered as a prominent risk factor for CV events. The management of these patients should be multidisciplinary, including cardiologists. Cureus 2021-06-17 /pmc/articles/PMC8290906/ /pubmed/34295575 http://dx.doi.org/10.7759/cureus.15716 Text en Copyright © 2021, Ali et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Ali, Azka
Ali, Akhtar
Kumar, Dilpat
Kumar, Ravi
Elahi, Kanwal
Suman, FNU
Anjum, Zauraiz
Tharwani, Payal
Jahangir, Maha
Rizwan, Amber
Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
title Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
title_full Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
title_fullStr Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
title_full_unstemmed Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
title_short Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
title_sort comparison of incidence of myocardial infarction in patients with rheumatoid arthritis and diabetes mellitus
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290906/
https://www.ncbi.nlm.nih.gov/pubmed/34295575
http://dx.doi.org/10.7759/cureus.15716
work_keys_str_mv AT aliazka comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT aliakhtar comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT kumardilpat comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT kumarravi comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT elahikanwal comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT sumanfnu comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT anjumzauraiz comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT tharwanipayal comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT jahangirmaha comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus
AT rizwanamber comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus